Clinical Trial Update: Neoadjuvant Platform Trial in Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant platform trial in non-small cell lung cancer sponsored by the Canadian Cancer Trials Group; the study is currently active but not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: NSCLC | Phase 2 | Status: ACTIVE_NOT_RECRUITING